M

    MBX Biosciences, Inc. Common Stock (MBX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $61.60
    -1.40 (-2.22%)

    Market Cap: $3.03B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    75%(6/8)
    Avg Surprise
    +9.09%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.84
    Range$-0.96 - $-0.74
    7 analysts
    EPS RevisionsNo revisions (7d)
    0
    4
    30d
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$-0.74+12.6%
    30d ago$-0.74+12.6%
    7d ago$-0.72+14.3%
    Current$-0.84
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Dec 31, 2026
    EPS Consensus$-1.07
    Range$-1.51 - $-0.88
    9 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.07---
    Sep 26EST
    		-$-0.84---
    Jun 26
    		$-0.78$-0.68-14.71%Miss-34.5%
    Mar 26
    		$-0.51$-0.58+12.07%Beat+28.2%
    Dec 25
    		$-0.49$-0.60+17.88%Beat-4.3%
    Sep 25
    		$-0.63$-0.68+7.35%Beat+77.3%
    Jun 25
    		$-0.58$-0.77+24.68%Beat+94.9%
    Mar 25
    		$-0.71$-0.77+7.79%Beat-
    Dec 24
    		$-0.47$-0.59+19.85%Beat-
    Sep 24
    		$-2.78$-2.72-2.21%Miss-
    Jun 24
    		$-11.47$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-25.56EV/EBITDAN/A
    Price/FCF-34.49xFCF Yield-2.90%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-33.20%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio18.08xQuick Ratio18.08x
    Trading Statistics
    BetaN/AAvg Volume432.67K
    52-Week High$72.6452-Week Low$9.63

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$66.04
    SMA 20$66.83
    SMA 50$61.88
    SMA 200$39.99
    EMA 10$65.39
    EMA 20$65.36
    EMA 50$60.04
    EMA 200$41.92

    MACD

    Line: 0.92Signal: 2.00Hist: -1.08

    ADX

    ADX: 25.3+DI: 17.2-DI: 26.3

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down4.0
    PSAR$70.14

    Bollinger Bands

    Upper Band$70.70
    Lower Band$62.95
    %B Position1160%(Upper)
    Band Width-0.17

    RSI (14-Day)

    Neutral
    43.1

    Momentum Oscillators

    Stoch %K20.2
    Stoch %D34.5
    Williams %R-79.7
    ROC (10d)-9.7%
    Momentum-6.65
    CCI (20d)-331.3
    MFI (14d)43.7

    Volatility Measures

    ATR (14d)$3.50(5.7%)
    StdDev (20d)1.94
    Hist Vol52.0%(High)

    Volume Flow

    VWAP$61.37
    OBV48.0M
    AD Line-4.7M
    CMF (20d)0.028

    Volume Metrics

    Avg Vol (20d)434.8K
    Vol Ratio1.2x
    VWMA (20d)$66.99

    Pivot Points

    R3$68.25
    R2$67.19
    R1$65.10
    Pivot Point$64.04
    S1$61.95
    S2$60.89
    S3$58.80

    Advanced Oscillators

    TSI8.21
    Ultimate Osc49.9
    KST65.06

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$222,000$0$0$0$0$0
    Cost of Revenue$0$0$60,000$0$0$0N/A$0$0$0N/A$0
    Gross Profit$0$0$-60,000$0$0$0$111,000$0$0$0N/A$0
    Operating Expenses$40.93M$27.27M$25.80M$23.93M$21.80M$26.53M$18.61M$19.61M$16.66M$13.31M$9.99M$10.95M
    R&D$30.98M$18.47M$19.76M$19.27M$17.72M$22.41M$15.22M$16.75M$14.40M$11.05M$7.73M$9.07M
    SG&A$9.95M$8.79M$6.04M$4.66M$4.08M$4.12M$3.39M$2.87M$2.26M$2.27M$2.26M$1.87M
    Operating Income$-40,931,000$-27,265,000$-25,795,000$-23,926,000$-21,805,000$-26,529,000$-18,610,000$-19,612,000$-16,658,000$-13,314,000$-9,991,000$-10,945,000
    Interest Income$3.84M$3.75M$3.73M$2.31M$2.39M$2.65M$3.02M$1.47M$801,000$977,000$1.15M$783,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-37,095,000$-23,517,000$-22,062,000$-21,618,000$-19,411,000$-23,880,000$-15,586,000$-18,142,000$-15,857,000$-12,337,000$-8,843,000$-10,162,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-37,095,000$-23,517,000$-22,062,000$-21,618,000$-19,411,000$-23,880,000$-15,586,000$-18,142,000$-15,857,000$-12,337,000$-8,843,000$-10,162,000
    EBITDA$-41,273,000$-27,780,000$-26,290,000$-24,610,000$-22,723,000$-27,795,000$-19,949,000$-20,124,000$-17,036,000$-13,769,000$-7,202,000$-10,945,000
    EBIT$-40,931,000$-27,265,000$-25,795,000$-23,926,000$-21,805,000$-26,529,000$-18,610,000$-19,612,000$-16,658,000$-13,314,000$-7,243,000$-10,945,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MBX

    News

    MBX BIOSCIENCES, INC. : JP MORGAN RESUMES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $88

    J.P. Morgan has resumed coverage on MBX Biosciences, Inc. (MBX.O) with an Overweight rating. The financial institution has set a target price of $88 for the company's stock. This news indicates a positive outlook from J.P. Morgan regarding MBX Biosciences' future performance.

    Bitget•8/21/26•
    Neutral

    JPMorgan Chase & Co. Initiates Coverage on MBX Biosciences (NASDAQ:MBX)

    JPMorgan Chase & Co. has initiated coverage on MBX Biosciences (NASDAQ:MBX) with an "overweight" rating and an $88 price target, suggesting a 32% upside. Despite this positive outlook, MBX reported a quarterly loss of $0.78 per share, missing estimates. Other analysts show mixed sentiment, with a consensus "Moderate Buy" rating but one "sell" rating from Weiss Ratings.

    MarketBeat•8/21/26•
    Somewhat-Bullish

    MBX BIOSCIENCES, INC. : JP MORGAN RESUMES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $88

    JP Morgan has resumed coverage of MBX BIOSCIENCES, INC. (MBX.O) with an Overweight rating. The firm has set a target price of $88 for the company's stock. This indicates a positive outlook from JP Morgan regarding MBX Biosciences' future performance.

    Bitget•8/21/26•
    Neutral

    MBX Biosciences (NASDAQ: MBX) insider to sell 3,745 shares

    MBX Biosciences insider Peter K. Hawryluk has filed a Form 144 to potentially sell 3,745 shares of common stock, valued at approximately $255,737.06. These shares are related to restricted stock vesting on August 14, 2026. Hawryluk previously sold 936 shares for $61,563.42 in the past three months.

    Stock Titan•8/17/26•
    Neutral

    California State Teachers Retirement System Purchases 21,011 Shares of MBX Biosciences, Inc. $MBX

    The California State Teachers Retirement System significantly increased its stake in MBX Biosciences by 1,197.9%, now holding 22,765 shares valued at $680,000. Other institutional investors also raised their positions in the company. Despite the company missing its Q2 earnings estimates, analysts maintain a "Moderate Buy" rating with an average price target of $75.62, and MBX Biosciences shares recently traded near their 52-week high.

    MarketBeat•8/15/26•
    Neutral

    Frequently Asked Questions About MBX

    Does MBX pay dividends?
    MBX Biosciences, Inc. Common Stock (MBX) does not currently pay a regular dividend.
    What is MBX's market cap?
    MBX Biosciences, Inc. Common Stock (MBX) has a market capitalization of $3.03B with a current stock price of $61.60.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In